Alessandro Agnarelli

6PUBLICATIONS
15CO-AUTHORS
Molecular targetsGenome structure and regulationPredictive and prognostic markersMedical infection agents (incl. prions)Cell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 05, 2026
Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors.

|Dec 03, 2025
The genetic and biochemical basis of human leading strand synthesis.

Alessandro Agnarelli, Lauryn Buckley-Benbow, Meryem Ozgencil

|Jan 08, 2023
The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor.

Alessandro Agnarelli, Andrea Lauer Betrán, Athanasios Papakyriakou

|Sep 23, 2022
Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications.

Alessandro Agnarelli, Viviana Vella, Mark Samuels

|May 11, 2022
Dissecting the impact of bromodomain inhibitors on the Interferon Regulatory Factor 4-MYC oncogenic axis in multiple myeloma.

Alessandro Agnarelli, Simon Mitchell, Gillian Caalim

|Jul 01, 2021
Phosphorus and sulfur SAD phasing of the nucleic acid-bound DNA-binding domain of interferon regulatory factor 4.

Alessandro Agnarelli, Kamel El Omari, Ramona Duman

Pageof 1

Frequent Collaborators

2 joint publications

Erika J Mancini

2 joint publications

Georgios Giamas

2 joint publications

Roberto Bellelli

2 joint publications

Lauryn Buckley-Benbow